Gabapentin as Adjunctive Treatment for Postoperative Pain Control

Completed · Phase 1 · Has a placebo group

Conditions studied: Drug Usage

In brief

The specific aims of this research study are to use 600 mg gabapentin as an adjunctive treatment for acute postoperative pain control in order to reduce postoperative opiate consumption and improve postoperative pain control.

Key facts

Study ID

NCT02490345

Run by

Indiana University

People needed

13

Starts

2015-10-01

Expected to finish

2017-06-29

Last updated by the study team

2017-08-23

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Pregnant women at least 18 years of age
• Singleton gestation
• Gestational age equal to or greater than 30 weeks
• Women undergoing a non-emergent (often scheduled) repeat cesarean delivery
• Spinal anesthesia utilized during cesarean

You may not qualify if…

• History of opiate abuse
• Women on opiates during pregnancy
• Women requiring treatment with magnesium sulfate postpartum
• Preexisting Fibromyalgia, chronic pain syndrome, or rheumatologic disorder
• General anesthesia required for cesarean
• Plans to breastfeed
• History of major depression or postpartum depression requiring medication
• Planned classical cesarean section

Where it is running

• Eskenazi Health — Indianapolis, Indiana, United States
• Eskenazi Hospital — Indianapolis, Indiana, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.